BioPharm International, May 2007 - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

BioPharm International, May 2007
Features
Separation & Purification: Endotoxin Reduction Using Disposable Membrane Adsorption Technology in cGMP Manufacturing
By Andrew Clutterbuck , James Kenworthy , John Liddell
Membrane-based chromatography technologies sometimes offer advantages over resin-based technologies.
Chromatography: A Two-Column Process To Purify Antibodies Without Protein A
By G.M. Ferreira , J. Dembecki , K. Patel , Alahari Arunakumari, PhD
This flexible setup minimizes the number of purification process steps, buffers, and process components.
Outsourcing: Transition from Business Process Outsourcing to Knowledge Process Outsourcing
By Hazel Aranha , Scott M. Wheelwright
By outsourcing high-end processes that demand advanced analytical and technical skills, biopharm companies are reaping substantial savings.
Columns and Departments
China Today: Intellectual Property Protection in China: Does it Warrant Worry?
By Eric S. Langer
China's central government is aware of the need to improve intellectual property protection and enforcement.
Final Word: Political Will is the Backbone of Regulation Enforcement
By Steven S. Kuwahara
Lax enforcement arising from a lack of political will creates the potential for a loss of public confidence.
From the Editor: Score One for Preparedness
By Laura Bush
Fortunately for all of us, not everyone's head is in the sand.
Outsourcing Insights: Booming Biopharma Pipeline Straining CRO Capacity
By Jim Miller
Venture capital insiders say that the flow of funds into biopharma shouldcontinue, driven by the large amount of money available for investment.
Regulatory Beat: Campaign Accelerates for Follow-on Biologics
By Jill Wechsler
The information provided by analytical testing is important in determining whether additional clinical trails are necessary to bring a follow-on to market.

ADVERTISEMENT

ADVERTISEMENT

Click here